2017 ESC/EACTS Guidelines for the management of valvular heart disease
Рекомендации ESC/EACTS 2017 года по ведению пациентов с клапанными пороками сердца
2017-08-26
SCID: 54.1/gbzsqs3z
Discuss with AI
ESC/EACTS guidelinescardio-thoracic surgeryclinical managementevidence-based recommendationsvalvular heart disease
Figures from the paper
Abstract (AI)
The Task Force for the Management of Valvular Heart Disease of the European Society of Cardiology (ESC) and the European Association for Cardio-Thoracic Surgery (EACTS) The disclosure forms of all experts involved in the development of these guidelines are available on the ESC website http://www.escardio.org/guidelines. Current background information and detailed discussion of the data for these Guidelines can be found in ESC CardioMed - Section 35 Valvular heart disease ... ... Guidelines summarize and evaluate available evidence with the aim of assisting health professionals in selecting the best management strategies for an individual patient with a given condition. Guidelines and their recommendations should facilitate decision making of health professionals in their daily practice. However, the final decisions concerning an individual patient must be made by the responsible health professional(s) in consultation with the patient and caregiver as appropriate. A great number of guidelines have been issued in recent years by the European Society of Cardiology (ESC) and by the European Association for Cardio-Thoracic Surgery (EACTS) as well as by other societies and organisations. Because of the impact on clinical practice, quality criteria for the development of guidelines have been established in order to make all decisions transparent to the user. The recommendations for formulating and issuing ESC Guidelines can be found on the ESC website (https://www.escardio.org/Guidelines/Clinical-Practice-Guidelines/Guidelines-development/Writing-ESC-Guidelines). ESC Guidelines represent the official position of the ESC on a given topic and are regularly updated.
Key Findings
1
Detailed supporting evidence and discussion are available through ESC CardioMed and the ESC website.
2
Final treatment decisions should be made by responsible healthcare professionals in consultation with the patient and caregiver when appropriate.
3
The 2017 ESC/EACTS guidelines provide evidence-based recommendations for managing valvular heart disease.
4
The guideline development process emphasizes transparency, quality criteria, expert disclosures, and regular updating of recommendations.
5
The guidelines aim to help healthcare professionals select individualized management strategies and support clinical decision-making in daily practice.
Research Object
Phonocardiographic signals reflecting the functional state of human heart valves (mitral insufficiency)
Research Subject
evidence-based management strategies for individual patients with valvular heart disease
Publication Details
Publication Date
2017-08-26
Journal
Publisher
ISSN
Cited by
6243
Open access PDF
Access Type
Author Information
Download PDF
Subscribe to digest
References available in scid.ai6
2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure2016
2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS2016
Transcatheter or Surgical Aortic-Valve Replacement in Intermediate-Risk Patients2016
Surgical or Transcatheter Aortic-Valve Replacement in Intermediate-Risk Patients2017
Two-Year Outcomes of Surgical Treatment of Severe Ischemic Mitral Regurgitation2015
Mitral-Valve Repair versus Replacement for Severe Ischemic Mitral Regurgitation2013
Cited by6
2020 ESC Guidelines for the management of adult congenital heart disease2020
2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy2018
The 2018 European Heart Rhythm Association Practical Guide on the use of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation2018
2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease2020
National Heart Foundation of Australia and Cardiac Society of Australia and New Zealand: Guidelines for the Prevention, Detection, and Management of Heart Failure in Australia 20182018
Percutaneous Repair of Moderate-to-Severe or Severe Functional Mitral Regurgitation in Patients with Symptomatic Heart Failure: Baseline Characteristics of Patients in the RESHAPE-HF2 Trial and Comparison to COAPT and MITRA-FR Trials2024